Literature DB >> 24565489

Successful treatment of idiopathic angioedema with ecallantide.

Alalia Berry1, Rafael Firszt2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24565489     DOI： 10.1016/j.jaip.2013.03.007

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


× No keyword cloud information.
  4 in total

Review 1.  Differential Diagnosis and Management Issues of Idiopathic Angiooedema and their Resolution.

Authors:  Andrea Zanichelli; Marta Mansi; Maddalena A Wu; Giulia Azin; Marco Cicardi
Journal:  J Crit Care Med (Targu Mures)       Date:  2015-06-05

Review 2.  Management of acute attacks of hereditary angioedema: role of ecallantide.

Authors:  Hannah Duffey; Rafael Firszt
Journal:  J Blood Med       Date:  2015-04-16

3.  Idiopathic non-histaminergic acquired angioedema: a case series and discussion of published clinical trials.

Authors:  Martin Christian Bucher; Tatjana Petkovic; Arthur Helbling; Urs Christian Steiner
Journal:  Clin Transl Allergy       Date:  2017-08-31       Impact factor: 5.871

4.  Omalizumab for Idiopathic Nonhistaminergic Angioedema: Evidence for Efficacy in 2 Patients.

Authors:  Enrico Brunetta; Dana Shiffer; Marco Folci; Maria I S Achenza; Francesca Puggioni; Enrico Heffler; Raffaello Furlan; Giorgio W Canonica
Journal:  Case Reports Immunol       Date:  2018-07-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.